8-K

SCIENTIFIC INDUSTRIES INC (SCND)

8-K 2021-01-08 For: 2020-01-08
View Original
Added on April 06, 2026

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_________________________________________________

FORM 8-K

_________________________________________________

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported):

January 8, 2021

_________________________________________________

SCIENTIFIC INDUSTRIES, INC.

_________________________________________________

(Exact name of registrant as specified in its charter)

Delaware 000-6658 04-2217279
(State<br>or other Jurisdiction) (Commission<br>File Number) (IRS<br>Employer No.)

80 Orville Drive, Suite 102

Bohemia, New York 11716

__________________________________________________

(Address of principal executive offices)

(631) 567-4700

__________________________________________________

(Registrant's telephone number, including area code)

Not Applicable

__________________________________________________

(Former name or former address, if changed since last report)

ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT

The Company and its wholly-owned subsidiary, Scientific Bioprocessing, Inc., have agreed to an extension through December 31, 2021 of the Monthly Retainer Agreement with Mr. Joseph G. Cremonese, a Director of the Company since November 2002, and his affiliate, Laboratory Innovation Company, Ltd. All other terms remain the same.

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On January 8, 2021, the Board accepted the resignation of Mr. John F.F. Watkins as a Class C Director. Mr. Watkins’ resignation was not the result of any dispute or disagreement with the Company. The Company will pay Mr. Watkins director fees through December 31, 2020.

ITEM 9.01 Financial Statements and Exhibits

(a) and (b) not applicable

(c) Exhibits

Exhibit No. Description
10.1 Amendment<br>to Monthly Retainer Agreement

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SCIENTIFIC INDUSTRIES, INC.
Date: January 8, 2021 By: /s/ Helena R. Santos_______________
Helena R. Santos,
President and Chief Executive Officer

docslib-266475v1scientifi

January 8, 2021

Mr. Joseph G. Cremonese

PO Box 1907

Greensburg, PA 15601

Laboratory Innovation Company, Ltd.

PO Box 1907

Greensburg, PA 15601

Dear Joe:

Please confirm your agreement by signing where indicated below that the term of your engagement and the engagement of Laboratory Innovation Company, Ltd. (collectively, the “Consultant”) pursuant to the Monthly Retainer Agreement, dated as of January 1, 2020, as amended and/or extended to date (the “Agreement”), with Scientific Bioprocessing, Inc. (the “Company”), a wholly-owned subsidiary of Scientific Industries, Inc., is hereby further extended to December 31, 2021, subject to earlier termination by written notice by either the Company or the Consultant delivered to the other party at least 60 days prior to the termination date set forth in the written notice.

There are no other changes to the Agreement.

Scientific<br>Industries, Inc.
By: /s/<br>Helena R. Santos
Helena<br>R. Santos
President<br>and CEO
Scientific<br>Bioprocessing, Inc.
--- ---
By: /s/<br>John A. Moore
John A.<br>Moore
President

Acknowledged and agreed to:

Joseph<br>G. Cremonese
/s/<br>Joseph G. Cremonese
Laboratory<br>Innovations, Ltd.
--- ---
By: /s/<br>Joseph G. Cremonese
Joseph<br>G. Cremonese
President